Clinical Trial Update: Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on vandetanib for children and adolescents with medullary thyroid carcinoma, including conditions related to multiple endocrine neoplasia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma
• Multiple Endocrine Neoplasia Type 2a
• Multiple Endocrine Neoplasia Type 2b

Drugs mentioned

• Vandetanib (vandetanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-22